Sperm Count Test Market Size - By Technique (Microscopy, Chromatographic Immunoassay & Calorimetric Reaction, Smartphone-based), By Age Group (34 & Below, 34 Years, 35-40 Years, 41 Years & Above), By End-use & Forecast, 2023

Description

List of Tables

Global Sperm Count Test Market size will amass substantial gains through 2032. Rapid industrialization across several economies has led to the construction of hospitals and other treatment facilities with advanced sperm count test kits, positively impacting the industry landscape. Moreover, industry growth can also be ascribed to the flourishing medical device sector globally. To illustrate, according to IBEF, the medical device industry in India has the potential to hit USD 50 billion by 2025.

The overall sperm count test market is divided based on technique, age group, end-use, and region.

Sperm count test market from the chromatographic immunoassay & calorimetric reaction segment will expand significantly through 2032. Both chromatographic immunoassay and calorimetric reaction offer high levels of accuracy and precision in sperm count testing, which favors their adoption. These methods can detect even small variations in sperm concentration, motility, and viability, enabling healthcare providers to make more informed decisions about the best course of treatment for their patients.

In terms of age group, sperm count test market share from the 34 years segment will grow at a lucrative CAGR from 2023 to 2032. Growing prevalence of infertility in males of this age has increased the need for sperm count tests. Moreover, this demographic is also susceptible to lifestyle disorders due to excessive alcohol intake and smoking, which affects their fertility. Segment growth can also be attributed to growing awareness about reproductive health among people of this age group.

Based on end use, the market value from the hospitals & clinics segment will grow notably through 2032. High availability of cost-effective diagnostic solutions in hospitals & clinics has increased patient footfall in these facilities. Moreover, surging government investments in building new hospitals & clinics will contribute to segment growth. In October 2022, the U.S. government unveiled an investment of more than USD 110 million to improve healthcare for rural people. This investment will help build hospitals & clinics in rural locations.

Europe sperm count test industry will witness appreciable growth during 2023-2032. Growing incidence of male infertility rates in the region has increased the demand for sperm count tests. Regional expansion can also be attributed to well-established healthcare infrastructure and the growing awareness about reproductive health. Europe also has a robust presence of market leaders such as Vitrolife AB, and others constantly engaged in product innovations. This will also favor the market dynamics over the estimation period.

Product Code: 5634

Chapter 1 Methodology & Scope

1.1 Methodology
1.2 Market scope & definitions
1.3 Base estimates and calculations
- 1.3.1 North America
- 1.3.2 Europe
- 1.3.3 Asia Pacific
- 1.3.4 Latin America
- 1.3.5 MEA
1.4 Forecast calculations
1.5 Data validation
1.6 COVID-19 impact analysis at global level
1.7 Data sources
- 1.7.1 Secondary
  - 1.7.1.1 Paid sources
  - 1.7.1.2 Unpaid sources
- 1.7.2 Primary

Chapter 2 Executive Summary

2.1 Sperm count test market industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Regional trends
- 2.1.3 Technique trends
- 2.1.4 Age group trends
- 2.1.5 End-use trends

Chapter 3 Sperm Count Test Industry Insights

3.1 Industry segmentation
3.2 Industry ecosystem analysis
3.3 Industry impact forces
- 3.3.1 Growth drivers
  - 3.3.1.1 Increasing male infertility rates
  - 3.3.1.2 Technological advancement in sperm count testing techniques
  - 3.3.1.3 Increasing demand for at-home testing
  - 3.3.1.4 Increasing awareness about male infertility across globe
- 3.3.2 Industry pitfalls & challenges
  - 3.3.2.1 Lack of awareness in developing countries
  - 3.3.2.2 High cost of test
3.4 Growth potential analysis
- 3.4.1 By technique
- 3.4.2 By age group
- 3.4.3 By end-use
3.5 COVID- 19 impact analysis
3.6 Regulatory landscape
- 3.6.1 U.S.
- 3.6.2 Europe
3.7 Technology landscape
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive landscape

4.1 Introduction
4.2 Company matrix analysis, 2021
4.3 Competitive dashboard
4.4 Company market share, 2021
4.5 Competitive analysis of major market players
4.6 Competitive positioning matrix
4.7 Strategic outlook matrix

Chapter 5 Sperm Count Test Market and Forecast, By Technique (USD Million)

5.1 Key trends, by technique
5.2 Microscopy
5.3 Chromatographic immunoassay & calorimetric reaction
5.4 Smartphone-based
5.5 Others

Chapter 6 Sperm Count Test Market and Forecast, By Age Group (USD Million)

6.1 Key trends, by age group
6.2 34 & below
6.3 34 years
6.4 35-40 years
6.5 41 years & above

Chapter 7 Sperm Count Test Market and Forecast, By End-use (USD Million)

7.1 Key trends, by end-use
7.2 Fertility centres
7.3 Hospital & clinics
7.4 Others

Chapter 8 Sperm Count Test Market and Forecast, By Region (USD Million)

8.1 Key regional trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Russia
- 8.3.7 Poland
- 8.3.8 Switzerland
- 8.3.9 Norway
- 8.3.10 Finland
- 8.3.11 Sweden
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Taiwan
- 8.4.7 Indonesia
- 8.4.8 Vietnam
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Colombia
- 8.5.5 Chile
8.6 Middle East & Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Israel

Chapter 9 Company Profiles

9.1 Medical Electronic Systems
9.2 Fertility Focus Inc
9.3 Andrology Solutions
9.4 Vitrolife AB
9.5 DxNow
9.6 Microptic S.L.
9.7 Hamilton Thorne
9.8 Artron Laboratories, Inc.
9.9 ExSeed Health
9.10 Olympus Corporation, Inc.
9.11 AB ANALITICA s.r.l.